These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 8498840
21. In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease. Matthews PM, Allaire C, Shoubridge EA, Karpati G, Carpenter S, Arnold DL. Neurology; 1991 Jan; 41(1):114-20. PubMed ID: 1985275 [Abstract] [Full Text] [Related]
22. P31-NMR studies of muscle in patients with venous insufficiency. Taheri SA, Pollack L, Loomis R. Int Angiol; 1987 Jan; 6(1):95-8. PubMed ID: 3624954 [Abstract] [Full Text] [Related]
23. In vivo assessment of mitochondrial functionality in human gastrocnemius muscle by 31P MRS. The role of pH in the evaluation of phosphocreatine and inorganic phosphate recoveries from exercise. Iotti S, Lodi R, Frassineti C, Zaniol P, Barbiroli B. NMR Biomed; 1993 Jan; 6(4):248-53. PubMed ID: 8217526 [Abstract] [Full Text] [Related]
25. Improved brain and muscle mitochondrial respiration with CoQ. An in vivo study by 31P-MR spectroscopy in patients with mitochondrial cytopathies. Barbiroli B, Iotti S, Lodi R. Biofactors; 1999 Jan; 9(2-4):253-60. PubMed ID: 10416038 [Abstract] [Full Text] [Related]
29. Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia. Park JH, Phothimat P, Oates CT, Hernanz-Schulman M, Olsen NJ. Arthritis Rheum; 1998 Mar; 41(3):406-13. PubMed ID: 9506567 [Abstract] [Full Text] [Related]
30. Magnetic resonance spectroscopy of normal and diseased muscles. Chance B, Younkin DP, Kelley R, Bank WJ, Berkowitz HD, Argov Z, Donlon E, Boden B, McCully K, Buist NM. Am J Med Genet; 1986 Dec; 25(4):659-79. PubMed ID: 2947466 [Abstract] [Full Text] [Related]
31. [In vivo investigations of stress susceptibility in pigs by means of magnetic resonance spectroscopy]. Kallweit E, Baulain U, Henning M, Kohn G. Dtsch Tierarztl Wochenschr; 1997 Sep; 104(9):380-3. PubMed ID: 9410728 [Abstract] [Full Text] [Related]
32. Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. Lodi R, Tonon C, Valentino ML, Iotti S, Clementi V, Malucelli E, Barboni P, Longanesi L, Schimpf S, Wissinger B, Baruzzi A, Barbiroli B, Carelli V. Ann Neurol; 2004 Nov; 56(5):719-23. PubMed ID: 15505825 [Abstract] [Full Text] [Related]
35. In vivo evidence for cerebral depletion in high-energy phosphates in progressive supranuclear palsy. Stamelou M, Pilatus U, Reuss A, Magerkurth J, Eggert KM, Knake S, Ruberg M, Schade-Brittinger C, Oertel WH, Höglinger GU. J Cereb Blood Flow Metab; 2009 Apr; 29(4):861-70. PubMed ID: 19190655 [Abstract] [Full Text] [Related]
36. [Visualizing muscular phosphorus metabolites in peripheral arterial occlusive disease]. Rexroth W, Semmler W, Gückel F, Stadtlander M, von Kaick G, Hild R. Vasa Suppl; 1988 Apr; 23():115-20. PubMed ID: 3206329 [No Abstract] [Full Text] [Related]
38. No structural or biochemical evidence for mitochondrial cytopathy in a case of alternating hemiplegia of childhood. Kyriakides T, Drousiotou A. Ann Neurol; 1994 Nov; 36(5):805-6. PubMed ID: 7979233 [No Abstract] [Full Text] [Related]